In a study published in the Proceedings of the National Academy of Sciences, researchers have revealed that amyloid fibrils formed by necroptosis mediators, RIPK1 and RIPK3, don't just form within ...

Dysfunction of microglia is known to play an important role in Alzheimer’s disease (AD). Here, we investigated the role of RIPK1 in microglia mediating the pathogenesis of AD. RIPK1 is highly ...

In a recent study published in the journal Nature Cell Biology, researchers investigated how N-acetyltransferase (NAT)-mediated post-translational modification, acetylhypusination, regulates insulin ...

Scientists at St. Jude Children's Research Hospital have discovered a new way that the molecule RIPK1 leads to cell death in infected, damaged or unwanted cells showing that more than one mechanism ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Receptor-interacting protein kinase 1 (RIPK1) is a Ser/Thr kinase that has a key role in cell death and inflammation initiated by death receptors. RIPK1 can promote two cellular fates downstream of ...

The IKK complex protects cells from death by inactivating RIPK1, thereby revealing an unexpected NF-kB-independent new role of the IKK complex, investigators have revealed. The team of Prof. Bertrand ...

Eli Lilly and Company will collaborate with Rigel Pharmaceuticals to develop a small-molecule inhibitor of RIPK1, a kinase involved in cell death and inflammation. Lilly will pay Rigel $125 million up ...

In another sizable deal for Denali Therapeutics, Sanofi is paying $125 million to buy into a series of neuroinflammation compounds called RIPK1 inhibitors. The pact provides key funding for the ...

Receptor-interacting protein kinase 1 (RIPK1) regulates cell cycle and counteracts necroptosis, and is hence considered a target to watch in necroptosis-related conditions such as cancer or ...